Close Menu

reagents

The reagent supplier now has three Japanese distributors following a 2013 deal with GeneDesign as a representative throughout that country.

Sigma-Aldrich will take over distribution of Roche's Biochemical Reagents product portfolio so Roche can focus on other areas of its business.

Qiagen said that Enzymatics' portfolio of reagents are estimated to be used in more than 80 percent of all global NGS sequencing reactions.

The shift back toward therapeutics marks a return to the company's initial focus, which it put on hold last year due to a challenging funding environment.

NEW YORK (GenomeWeb News) — Biofortuna said today that it has received 510(k) clearance from the US Food and Drug Administration for its SSPGo HLA PCR kits.

NEW YORK (GenomeWeb News) – Researchers at Brown University and the St. Laurent Institute have found ties between RNA editing and transposon-related gene silencing in fruit flies — findings that they suspect may extend to other organisms.

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported a 4 percent increase in its third quarter revenues, as the company beat the consensus Wall Street estimate on the top line but missed on the bottom line.

NEW YORK (GenomeWeb News) – SeraCare Life Sciences today said that it has acquired Kirkegaard & Perry Laboratories, a supplier of antibodies and reagents for the life science research and diagnostics markets.

NEW YORK (GenomeWeb News) – UK molecular diagnostics firm Biofortuna today announced a £1.3 million investment ($2.0 million), which will go toward the expansion of its custom service and manufacturing business.

NEW YORK (GenomeWeb News) – Sigma-Aldrich today said it is partnering with the Scripps Research Institute to develop and commercialize new reagents.

Pages

Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.

Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.

Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.

In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.